OCT-angiography as a Pronostic Marker for Visual Impairment in Patients Undergoing Neurosurgery for Compressive Macroadenoma : a Prospective Study.

Centre Hospitalier Universitaire de Nice21 enrolled

Overview

The aim of the study is to assess accurancy of OCT angiography as a pronostic marker for patients undergoing neurosurgery for compressiver macroadenoma as compared with visual acuity, visual field and OCT.

Study Type

INTERVENTIONAL

Allocation

NON_RANDOMIZED

Purpose

PREVENTION

Masking

NONE

Enrollment

Conditions

Pituitary Adenoma

Interventions

NeurosurgeryPROCEDURE

adenoma removal

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * pituitary compressive adenoma (for experimental group) * pituitary non compressive adenoma Exclusion Criteria: * retinian disease * amblyopia * parkinson disease * pregnant woman

Locations (2)

CHU de NICE

Nice, France

Hôpital Pasteur 2 - Service d'Ophtalmologie

Nice, France

Outcomes

Primary Outcomes

change of middle deviation

visual field evolution assessed by Middle deviation

Time frame: before surgery (= inclusion), 4 months after surgery and 10 months after surgery

Change of visual function index

visual field evolution assessed by visual function index

Time frame: before surgery (= inclusion), 4 months after surgery and 10 months after surgery

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.